Astegolimab
Modify Date: 2024-01-04 10:20:47
Astegolimab structure
|
Common Name | Astegolimab | ||
|---|---|---|---|---|
| CAS Number | 2173054-79-8 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of AstegolimabAstegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research[1]. |
| Name | Astegolimab |
|---|
| Description | Astegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research[1]. |
|---|---|
| Related Catalog | |
| Target |
ST2 |
| References |
| No Any Chemical & Physical Properties |